Carboxytherapy for Periorbital Dark Circles

Evaluation of the Use of Carboxytherapy in Periorbital Dark Circles

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT04745078

Enrollment

Registered

2021-02-09

Start date

2017-01-01

Completion date

2021-05-15

Last updated

2021-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Periorbital Disorder

Keywords

carboxytherapy, dark circles

Brief summary

the study evaluates carboxytherapy for the treatment of periorbital dark circles

Detailed description

two different concentrations of carboxytherapy administered to patients are compared regarding efficacy

Interventions

OTHERCaboxy30

carboxy30 to periorbital dark halos

OTHERCaboxy60

carboxy60 to periorbital dark halos

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

SINGLE (Subject)

Eligibility

Sex/Gender

ALL

Age

18 Years to 60 Years

Healthy volunteers

Yes

Inclusion criteria

* healthy individuals with dark circles

Exclusion criteria

* infections, scarring, pregnancy, allergy, on treatment for the condition.

Design outcomes

Primary

Measure	Time frame	Description
Improvement of Melanin index	6 weeks	change in melanin index of the dark circles
Improvement of erythema index	6 weeks	change in erythema index of the dark circles

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026